Sponsor:
DualityBio Inc.
Code:
NCT06018337
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
DB-1303/BNT323
Capecitabine
Paclitaxel
Nab-paclitaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by DualityBio Inc. on 2025-02-28.